SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-22-002581
Filing Date
2022-03-01
Accepted
2022-03-01 17:21:46
Documents
8

Document Format Files

Seq Description Document Type Size
1 424B5 feb_2022_atm_amendment.htm 424B5 731202
2 GRAPHIC img44015715_0.jpg GRAPHIC 22506
3 GRAPHIC img44015715_1.jpg GRAPHIC 240510
4 GRAPHIC img44015715_2.jpg GRAPHIC 18304
5 GRAPHIC img44015715_3.jpg GRAPHIC 141433
6 GRAPHIC img44015715_4.jpg GRAPHIC 75484
7 GRAPHIC img44015715_5.jpg GRAPHIC 18304
8 GRAPHIC img44015715_6.jpg GRAPHIC 22506
  Complete submission text file 0000950170-22-002581.txt   1475474
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-235372 | Film No.: 22699811
SIC: 2834 Pharmaceutical Preparations